# AxioMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/axiomed

- Industry: Medical Devices & Equipment
- Headquarters: Malden, US
- Website: http://www.axiomed.com
- Total disclosed funding: $54M
- Latest round: Series D (May 22, 2012)
- Investors on record: 9

## About

AxioMed LLC specializes in developing advanced viscoelastic spinal disc replacements aimed at treating degenerative disc disease, enhancing spinal health through innovative medical devices.Founded in 2001 in Malden, US, AxioMed LLC focuses on spinal health solutions and has undergone several strategic developments. The CEO and founder’s detailed background is not publicly available. The company has raised a total of USD 1.030 mn across its funding efforts, with the most recent financing round occurring on January 26, 2017, amounting to USD 1.025 mn.AxioMed's primary offerings are advanced viscoelastic spinal disc replacements, specifically designed to address degenerative disc disease. Their core products, including the Freedom® Lumbar Disc, Freedom® Cervical Disc, and Freedom® Lateral Lumbar Disc, utilize a proprietary silica-based viscoelastic material that closely mimics the natural human disc's biomechanical properties. These devices are engineered for flexibility and support, assisting patients in achieving pain relief and restoring normal spinal function. The discs have been implanted in over 800 patients across North America, Europe, Australia, and Jamaica, with a focus on enhancing patient outcomes in spinal health. Additionally, the company's spinout, AxioMEDx, is pioneering smart sensor technologies to further optimize these disc replacements and improve patient monitoring.AxioMed generates revenue through direct sales of its viscoelastic spinal disc replacements to healthcare providers and hospitals engaged in orthopedic and spinal surgeries. The business model is structured around B2B transactions, where medical institutions purchase the Freedom® products to treat patients with degenerative conditions. The flagship Freedom® Lumbar Disc, along with other specialized offerings, is sold within markets in the USA, Europe, Australia, and Jamaica, reflecting the company's commitment to expanding its reach. As the company continues to innovate, such as with the development of the Freedom DiscSx—a smart total disc replacement—there are opportunities for partnerships with healthcare organizations to facilitate broader adoption of their products.AxioMed's strategy for future growth includes the development of new products, with a focus on enhancing its smart disc replacement technologies. Recent funding raised on January 26, 2017, totaling USD 1.025 mn, will support these initiatives. The company plans to expand its market presence beyond current regions, targeting new healthcare markets in Asia and South America by 2025, aiming to improve accessibility to its advanced spinal health solutions.

## Funding rounds

- Series D, May 22, 2012, $5M — Blue Chip Venture Company, CID Capital, Primus, Thomas, McNerney & Partners, Early Stage Partners, Reservoir Venture Partners, MB Venture Partners, Patricia Industries
- Series D, Feb 10, 2012, $4.2M — Thomas, McNerney & Partners, MB Venture Partners, Patricia Industries, Primus Capital
- Series D, Jun 29, 2011, $3.2M — CID Capital, Thomas, McNerney & Partners
- Series D, Jul 19, 2010, $15M — CID Capital, Primus, Thomas, McNerney & Partners, Early Stage Partners, Reservoir Venture Partners, MB Venture Partners, Patricia Industries
- Series C, Dec 31, 2009, $6.4M — CID Capital, Thomas, McNerney & Partners
- Series B, Feb 23, 2005, $18M — CID Capital, Primus, Thomas, McNerney & Partners, Early Stage Partners, Reservoir Venture Partners, MB Venture Partners, Patricia Industries
- Series A, Jan 1, 2003, $2.8M — CID Capital, Primus, Early Stage Partners, Reservoir Venture Partners

## Investors

- CID Capital (https://capitalatlas.ai/funds/cid-capital) — Series A, Series B, Series C, Series D
- Primus (https://capitalatlas.ai/funds/primus) — Series A, Series B, Series D
- Early Stage Partners (https://capitalatlas.ai/funds/early-stage-partners) — Series A, Series B, Series D
- Reservoir Venture Partners (https://capitalatlas.ai/funds/reservoir-venture-partners) — Series A, Series B, Series D
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series B, Series C, Series D
- MB Venture Partners (https://capitalatlas.ai/funds/mb-venture-partners) — Series B, Series D
- Patricia Industries (https://capitalatlas.ai/funds/patricia-industries) — Series B, Series D
- Primus Capital (https://capitalatlas.ai/funds/primus-capital) — Series D
- Blue Chip Venture Company (https://capitalatlas.ai/funds/blue-chip-venture-company) — Series D